Showing results (1711-1720 of 1,912) with videos related to
Sort By:
Pageof 192
The Canadian Journal of Cardiology|October 12, 2023
The 2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT IntervalRoss A Davies, Virginie Beauséjour Ladouceur, Martin S Green, et al.SLAS Discovery : Advancing Life Sciences R & D|April 28, 2018
Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS CollectionSubhas J Chakravorty, James Chan, Marie Nicole Greenwood, et al.Journal of Translational Medicine|July 18, 2018
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancerDaniel S Green, Ana T Nunes, Virginia David-Ocampo, et al.Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modificationXicheng Sun, Jian Qiu, Sarah A Strong, et al.Frontiers in Neurology|July 9, 2026
Intra-cardiac thrombus detection by electrocardiogram-gated cardiac computed tomography in hyperacute ischemic strokeDaniel S Green, Timmy Pham, Dennis J Cordato, et al.Plos One|February 15, 2013
Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyureaNancy S Green, Katherine L Ender, Farzana Pashankar, et al.Multiple Sclerosis and Related Disorders|July 11, 2022
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosisK Allen-Philbey, A Stennett, T Begum, et al.Blood|July 31, 2010
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemiaNicolas Chapuis, Sophie Park, Laurent Leotoing, et al.CJC Open|June 22, 2026
MAX-SHOCK: A Pragmatic Randomized Controlled Trial Comparing Biphasic Defibrillators Used in Routine Cardioversion of Atrial FibrillationMehrdad Golian, F Daniel Ramirez, Mark Cleland, et al.Human Mutation|May 12, 2018
Evidence for GALNT12 as a moderate penetrance gene for colorectal cancerDaniel R Evans, Srividya Venkitachalam, Leslie Revoredo, et al.Pageof 192